Detalhe da pesquisa
1.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
N Engl J Med
; 387(21): 1923-1934, 2022 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342113
2.
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
N Engl J Med
; 384(2): 105-116, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33185990
3.
The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF.
J Card Fail
; 30(1): 26-35, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37683911
4.
Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus in the DECLARE-TIMI 58 trial.
Eur Heart J
; 43(31): 2958-2967, 2022 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34427295
5.
Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial.
Eur Heart J
; 43(23): 2212-2220, 2022 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325102
6.
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial.
Eur Heart J
; 43(41): 4362-4373, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35900838
7.
Effects of Serelaxin in Patients with Acute Heart Failure.
N Engl J Med
; 381(8): 716-726, 2019 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31433919
8.
Left Ventricular Strain and Rotation in Patients with Dilated Cardiomyopathy and Severe Systolic Dysfunction.
Cardiology
; 145(1): 1-12, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31715595
9.
External Validation of the MEESSI Acute Heart Failure Risk Score: A Cohort Study.
Ann Intern Med
; 170(4): 248-256, 2019 02 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30690646
10.
Effect of a Strategy of Comprehensive Vasodilation vs Usual Care on Mortality and Heart Failure Rehospitalization Among Patients With Acute Heart Failure: The GALACTIC Randomized Clinical Trial.
JAMA
; 322(23): 2292-2302, 2019 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31846016
11.
Torsion Mechanics as an Indicator of More Advanced Left Ventricular Systolic Dysfunction in Secondary Mitral Regurgitation in Patients with Dilated Cardiomyopathy: A 2D Speckle-Tracking Analysis.
Cardiology
; 139(3): 187-196, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29408823
12.
Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial.
Lancet
; 388(10062): 2895-2903, 2016 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27914656
13.
Darapladib for preventing ischemic events in stable coronary heart disease.
N Engl J Med
; 370(18): 1702-11, 2014 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24678955
14.
Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial.
Eur Heart J
; 37(4): 400-8, 2016 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26443023
15.
ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Rationale and Design.
Vnitr Lek
; 63(1): 43-48, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28225290
16.
ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Basic Epidemiology.
Vnitr Lek
; 63(1): 25-30, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28225288
17.
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.
N Engl J Med
; 367(14): 1297-309, 2012 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-22920930
18.
Association of the trimethylamine N-oxide with cardiovascular risk and vascular alterations in middle-aged patients with risk factors for cardiovascular diseases.
Biosci Rep
; 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38669041
19.
Hiatal Hernia: The Great Masquerade in the Emergency Department.
Eur J Case Rep Intern Med
; 10(4): 003834, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37051480
20.
Rationale and design of ENDEAVOR: A sequential phase 2b-3 randomized clinical trial to evaluate the effect of myeloperoxidase inhibition on symptoms and exercise capacity in heart failure with preserved or mildly reduced ejection fraction.
Eur J Heart Fail
; 25(9): 1696-1707, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37470101